1 / 67

Elective Project

Elective Project. Platelets Disorders. Presented by: Noor Abdulatif Maitha Salem Noor Safa Farah Hisham. Objectives. Events of hemostasis Mechanism of vasoconstriction, platelets plug, blood coagulation. Structure & function of platelets Normal blood count and causes of variation

cutler
Télécharger la présentation

Elective Project

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Elective Project • Platelets Disorders • Presented by: • Noor Abdulatif • Maitha Salem • Noor Safa • Farah Hisham

  2. Objectives • Events of hemostasis • Mechanism of vasoconstriction, platelets plug, blood coagulation. • Structure & function of platelets • Normal blood count and causes of variation • Blood coagulation tests • Platelets disorders • Disorder in number. • Disorder in function. • Deferential diagnosis of bleeding disorders.

  3. Hemostasis

  4. Hemostasis Response to Injury

  5. Hemostasis - Vasoconstriction

  6. Hemostasis - Vasoconstriction

  7. Platelets • Platelets (thrombocytes) are fragment of the cytoplasm of megakaryocyte. • They are small, colourless, andnon nucleated cells. • Shape: spherical or rod shaped • Size: 1 to 4 μmindiameter. • Life span: 8 – 10 days • Normal count: 150,000 to 450,000 / μl

  8. Platelets Structure

  9. Thrombopoiesis

  10. Phospholipids, relaese of clotting factors,and Ca2+ Functions of Platelets • Glycoprotein on the surface coat that adhere it to injured endothelial cells. • Prevent • Bleeding • Blood • Clotting

  11. Functions of Platelets • Secretes growth factor PDGF that promotes growth & multiplication of vascular endothelial cells • Actin, myosin & thrombosthenin • that are contractile proteins • Clot • Retraction • Repair damaged vascular wall

  12. Hemostasis - Plug Formation Formation of platelet plug:

  13. Hemostasis - Plug Formation Platelet Adhesion :

  14. Hemostasis - Plug Formation Platelet Activation :

  15. Hemostasis - Plug Formation Platelets aggregation :

  16. Hemostasis - Plug Formation

  17. Hemostasis - Blood Coagulation

  18. Hemostasis - Blood Coagulation

  19. Hemostasis - Blood Coagulation Conversion of Fibrinogen to Fibrin :

  20. Hemostasis Prevention of Blood Clotting in the Normal Vascular System—Intravascular Anticoagulants The smoothness of the endothelial cell surface, which prevents contact activation of the intrinsic clotting system; A layer of glycocalyx on the endothelium (glycocalyx is a mucopolysaccharide adsorbed to the surfaces of the endothelial cells), which repels clotting factors and platelets, thereby preventing activation of clotting; and An alphaglobulin called antithrombin III or antithrombin-heparin cofactor. Heparin

  21. Hemostasis A protein bound with the endothelial membrane, thrombomodulin, which binds thrombin ▼ Prevent clotting in normal vascular system BUT HOW?

  22. Hemostasis – Lysis of Blood Clots • The plasma proteins contain an euglobulin called plasminogen (or profibrinolysin) that, when activated, becomes a substance called plasmin (or fibrinolysin). • Plasmin digests fibrin fibers and some other protein coagulants such as fibrinogen, Factor V, Factor VIII, prothrombin, and Factor XII. • It can cause lysis of a clot by destroying many of the clotting factors, thereby sometimes even causing hypocoagulability of the blood.

  23. Hemostasis – Lysis of Blood Clots • The injured tissues and vascular endothelium very slowly release a powerful activator called tissue plasminogen activator (t-PA) that a few days later, after the clot has stopped the bleeding. • Converts plasminogen to plasmin, which in turn removes the remaining unnecessary blood clot.

  24. Assesment of hemostatic functions • Bleeding time. • Clotting time. • Prothrombin time and international normalized ratio. • Activated Partial Thromboplastin Time test

  25. Bleeding time • Bleeding usually stops within 1 to 6 minutes. • Lack of any one of the several of the clotting factors can prolong the bleeding time, but it is especially prolonged by lack of platelets.

  26. Clotting time • Normal clotting time: 6 to 10 minutes. • No longer used in many clinics.

  27. Prothrombin Time • How it is performed: • Adding the patient's plasma to some source of Tissue Factor and Calcium chloride. • PTT measures: • The integrity of the extrinsic system as well as factors common to both systems. • Normal PT Values: 10-12 seconds.

  28. International Normalized Ratio The INR is used to make sure the results from a PT test is the same at one lab as it is at another lab. Normal INR Values: 1 to 2

  29. Activated Partial ThromboplastinTime • The test is performed to: • Determine if heparin therapy is effective. • Detect the presence of a clotting disorder. • How it is performed: • Calcium and activating substances (kaolin and cephalin) are added. • PTT measures: • The integrity of the intrinsic system (Factors XII, XI, VIII, IX) and common clotting pathways. • Normal PTT Values: 30 to 45 seconds

  30. Causes of abnormal hemostasis Causes of abnormal hemostasis: • Platelets disorders. • Coagulation disorders. • Blood vessel wall disorder. • Fibrinolysisdisorders.

  31. Thrombocytosis • Thrombocytopenia • Acquired • Inherited • Disorders in Number • Disorders in Function • Platelets Disorders

  32. Causes of variation in platelets count • A normal platelet count in a healthy individual is between 150,000 and 450,000 / μl of blood. • Thrombocytopenia is the term used for cases having low platelets count. • Thrombocytosis is the term used for cases having high platelets count. • An abnormality or disease of the platelets is called a thrombocytopathy.

  33. Disorders in Number - Thrombocytosis Thrombocytosis: • It is a disorder in which the body produces too many platelets (> 500,000\μl) • When it’s caused by a blood and bone marrow disease, it is called essential/primary thrombocythemia. • When it's caused by an underlying condition, it is called reactive/secondary thrombocytosis.

  34. Disorders in Number - Thrombocytosis Essential Thrombocythemia • What causes this to happen usually is unknown. • Faulty stem cells in the bone marrow make too many platelets. • The platelets are abnormal in primary thrombocythemia. • A rare form of thrombocythemia is inherited.

  35. Disorders in Number - Thrombocytosis Reactive Thrombocytosis • Some of the conditions or factors that can cause a high platelet count are: • Cancer • Iron-deficiency anemia. • Acute hemolytic anemia. • Splenectomy. • Inflammatory or infectious diseases.

  36. Disorders in Number - Thrombocytosis Symptoms & Signs • People who have primary thrombocythemia are more likely than those who have secondary thrombocytosis to have serious signs and symptoms. • They include: • Weakness • Thrombosis • Headache • Dizziness • Chest pain • Numbness in the hands and feet.

  37. Disorders in Number - Thrombocytosis Treatment • Essential thrombocythemia: • Medications: - Hydroxyurea. • Plateleltpheresis • Reactive thrombocytosis istreated by treating the underlying cause.

  38. Disorders in Number - Thrombocytopenia  Thrombocytopenia  • Presence of low numbers of platelets (<150,000/μl) in the circulating blood. • Classification: • Mild (100,000-150,000/μl) • Moderate (50,000-100,000/μl) • Severe (<50,000/μl) • Serious ( <5000/μl) • Bleeding is usually from many small venules or capillaries. • The skin displays many small, purplish blotches, giving the disease the name thrombocytopenic purpura.

  39. Disorders in Number - Thrombocytopenia  Causes Production failure: • Bone marrow diseases. Consumptive disorder (the platelets are destroyed in the peripheral circulation & spleen): • Autoimmune diseases (ITP). • Infections. • Splenomegaly. • Medicines: - Heparin - Some antibiotics

  40. Disorders in Number - Thrombocytopenia  Symptoms & Signs External bleeding: - Purpura and petechiae - Nosebleed - Prolonged bleeding from minor cuts Internal bleeding: - Blood in the urine or stool

  41. Purpura • Purpura: bleeding under the skin or into mucosal membranes. • Purpura can be subdivided based on size into petechiae and ecchymoses. • Pinpoint areas (less than 2 mm) of hemorrhage, which are reddish-purple lesions are called petechiae. • Larger confluent lesions are referred to as ecchymoses. • Ecchymoses are commonly called bruises.

  42. Disorders in Number - Thrombocytopenia Treatment • Medicines: • Steroids. • IV immunoglobulins. • Anti-Rh antibody. • Blood or platelets transfusion. • Splenectomy. • Immunosuppressnt agent.

  43. Thrombocytosis • Thrombocytopenia • Acquired • Inherited • Disorders in Number • Disorders in Function • Platelets Disorders

  44. Disorders in Function - Inherited

  45. Disorders in Function – Von Willebrand’s Disease

  46. Disorders in Function –Bernard-Soulier Syndrome • An autosomal recessive disorder • Deficiency on the surface of the platelet in Glycoprotein Ib/IX. • Platelets fail to stick and clump together at the site of the injury. • Bleeding time is prolonged, and platelets count is low.

  47. Disorders in Function – Glanzmann’s Thrombasthenia

  48. Disorders in Function - Inherited

More Related